Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.

<h4>Background</h4>The role of the immune response in influencing leptospirosis clinical outcomes is not yet well understood. We hypothesized that acute-phase serum cytokine responses may play a role in disease progression, risk for death, and severe pulmonary hemorrhage syndrome (SPHS)....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eliana A G Reis, José E Hagan, Guilherme S Ribeiro, Andrea Teixeira-Carvalho, Olindo A Martins-Filho, Ruth R Montgomery, Albert C Shaw, Albert I Ko, Mitermayer G Reis
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Acceso en línea:https://doaj.org/article/d4275c8a18034fd296ff0787b58b5527
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d4275c8a18034fd296ff0787b58b5527
record_format dspace
spelling oai:doaj.org-article:d4275c8a18034fd296ff0787b58b55272021-11-18T09:16:51ZCytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.1935-27271935-273510.1371/journal.pntd.0002457https://doaj.org/article/d4275c8a18034fd296ff0787b58b55272013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24069500/pdf/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>The role of the immune response in influencing leptospirosis clinical outcomes is not yet well understood. We hypothesized that acute-phase serum cytokine responses may play a role in disease progression, risk for death, and severe pulmonary hemorrhage syndrome (SPHS).<h4>Methodology/principal findings</h4>We performed a case-control study design to compare cytokine profiles in patients with mild and severe forms of leptospirosis. Among patients hospitalized with severe disease, we compared those with fatal and nonfatal outcomes. During active outpatient and hospital-based surveillance we prospectively enrolled 172 patients, 23 with mild disease (outpatient) and 149 with severe leptospirosis (hospitalized). Circulating concentrations of pro- and anti-inflammatory cytokines at the time of patient presentation were measured using a multiplex bead array assay. Concentrations of IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17A, and TNF-α were significantly higher (P<0.05) in severe disease compared to mild disease. Among severe patients, levels of IL-6 (P<0.001), IL-8 (P = 0.0049) and IL-10 (P<0.001), were higher in fatal compared to non-fatal cases. High levels of IL-6 and IL-10 were independently associated (P<0.05) with case fatality after adjustment for age and days of symptoms. IL-6 levels were higher (P = 0.0519) among fatal cases who developed SPHS than among who did not.<h4>Conclusion/significance</h4>This study shows that severe cases of leptospirosis are differentiated from mild disease by a "cytokine storm" process, and that IL-6 and IL-10 may play an immunopathogenic role in the development of life-threatening outcomes in human leptospirosis.Eliana A G ReisJosé E HaganGuilherme S RibeiroAndrea Teixeira-CarvalhoOlindo A Martins-FilhoRuth R MontgomeryAlbert C ShawAlbert I KoMitermayer G ReisPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 7, Iss 9, p e2457 (2013)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Eliana A G Reis
José E Hagan
Guilherme S Ribeiro
Andrea Teixeira-Carvalho
Olindo A Martins-Filho
Ruth R Montgomery
Albert C Shaw
Albert I Ko
Mitermayer G Reis
Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
description <h4>Background</h4>The role of the immune response in influencing leptospirosis clinical outcomes is not yet well understood. We hypothesized that acute-phase serum cytokine responses may play a role in disease progression, risk for death, and severe pulmonary hemorrhage syndrome (SPHS).<h4>Methodology/principal findings</h4>We performed a case-control study design to compare cytokine profiles in patients with mild and severe forms of leptospirosis. Among patients hospitalized with severe disease, we compared those with fatal and nonfatal outcomes. During active outpatient and hospital-based surveillance we prospectively enrolled 172 patients, 23 with mild disease (outpatient) and 149 with severe leptospirosis (hospitalized). Circulating concentrations of pro- and anti-inflammatory cytokines at the time of patient presentation were measured using a multiplex bead array assay. Concentrations of IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17A, and TNF-α were significantly higher (P<0.05) in severe disease compared to mild disease. Among severe patients, levels of IL-6 (P<0.001), IL-8 (P = 0.0049) and IL-10 (P<0.001), were higher in fatal compared to non-fatal cases. High levels of IL-6 and IL-10 were independently associated (P<0.05) with case fatality after adjustment for age and days of symptoms. IL-6 levels were higher (P = 0.0519) among fatal cases who developed SPHS than among who did not.<h4>Conclusion/significance</h4>This study shows that severe cases of leptospirosis are differentiated from mild disease by a "cytokine storm" process, and that IL-6 and IL-10 may play an immunopathogenic role in the development of life-threatening outcomes in human leptospirosis.
format article
author Eliana A G Reis
José E Hagan
Guilherme S Ribeiro
Andrea Teixeira-Carvalho
Olindo A Martins-Filho
Ruth R Montgomery
Albert C Shaw
Albert I Ko
Mitermayer G Reis
author_facet Eliana A G Reis
José E Hagan
Guilherme S Ribeiro
Andrea Teixeira-Carvalho
Olindo A Martins-Filho
Ruth R Montgomery
Albert C Shaw
Albert I Ko
Mitermayer G Reis
author_sort Eliana A G Reis
title Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
title_short Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
title_full Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
title_fullStr Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
title_full_unstemmed Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
title_sort cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/d4275c8a18034fd296ff0787b58b5527
work_keys_str_mv AT elianaagreis cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT joseehagan cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT guilhermesribeiro cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT andreateixeiracarvalho cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT olindoamartinsfilho cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT ruthrmontgomery cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT albertcshaw cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT albertiko cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
AT mitermayergreis cytokineresponsesignaturesindiseaseprogressionanddevelopmentofsevereclinicaloutcomesforleptospirosis
_version_ 1718420931297148928